« PCV Testing Mini-Primer - GSK & Merck Rotavirus Contamination | Main | Novo Nordisk's Victoza® (GLP-1 analog) cardiovascular outcomes trial »
Here is an update on the Genzyme battle for the board as reported in Cliff Mintz's BioJobBlog. Genzyme has returned fire by authorizing a significant stock buy back and divesting non-performing business units (assets of sorts) in response to Icahn's overtures.
Genzyme Pushes Back : Bio Job Blog
Posted using ShareThis by Bruce Lehr May 7th 2010
| | |
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b01348096feeb970c
Listed below are links to weblogs that reference Genzyme Pushes Back in Board Battle Royale:
You can follow this conversation by subscribing to the comment feed for this post.
The comments to this entry are closed.
For more on this story refer to Fierce Biotech account too.
http://www.fiercebiotech.com/story/genzyme-jettison-three-units-it-bunkers-down/2010-05-07?utm_medium=rss&utm_source=rss
Posted by: Bruce Lehr | 05/07/2010 at 09:48 PM